feedback

Faculty

Alan C. Moss
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI

Associate Professor of Medicine
Harvard Medical School
Gastroenterologist
Director Translational Research, Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Boston, MA

Raluca Vrabie
Raluca Vrabie, MD

Assistant Professor of Clinical Medicine
Stony Brook School of Medicine
IBD Program Director
Winthrop University Hospital
Mineola, NY

Jason K. Hou
Jason K. Hou, MD

Assistant Professor of Medicine
Research Director, Inflammatory Bowel Disease Center
Program Director, Gastroenterology Fellowship Program
Baylor College of Medicine
Medical Director, Inflammatory Bowel Diseases
Michael E. DeBakey VA Medical Center
Houston, TX

Jointly Provided By


This activity is jointly provided by Postgraduate Institute for Medicine, the Crohn's & Colitis Foundation of America, and RMEI Medical Education, LLC.

Activity Details

Credit Type: AMA PRA Category 1 Credit(s)
Credit Amount: 1.25
Release Date: October 25, 2016
Expiration Date: December 24, 2017
Estimated Time to Complete Activity: 1.25 hours
Registration Required: No
Fee for Activity: There is no fee for this educational activity.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Identify IBD patients with anemia or iron deficiency
  2. Summarize evaluation criteria for anemia or iron deficiency using the CCFA IBD Anemia Care Pathway
  3. Describe intervention and follow up steps outlined by the CCFA IBD Anemia Care Pathway for patients who have anemia or iron deficiency
  4. Engage IBD patients with anemia or iron deficiency in their healthcare by implementing effective shared decision making strategies

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists and gastroenterology nurse practitioners (NPs) and physician assistants (PAs).

Requirements for Successful Completion

75%

Media

Internet

Conflict of Interest Policy / Disclosure Statement

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI has no affiliations with commercial interests to disclose.
  • Raluca Vrabie, MD has no affiliations with commercial interests to disclose.
  • Jason K. Hou, MD has affiliations with Pfizer, UCB (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents); Celgene, AbbVie, Pfizer, Redhill Biopharma (Contracted Research); AbbVie, UCB, Valeant (Speaker’s Bureau)

Crohn’s & Colitis Foundation of America

  • Orna Ehrlich, MPH, has no affiliations with commercial interests to disclose.

RMEI Medical Education, LLC

  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Nora Hartley has no affiliations with commercial interests to disclose.

Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the Crohn’s & Colitis Foundation of America (CCFA), and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.25 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page.
Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Statement of Commercial Support

This activity is supported by an independent medical educational grant from Luitpold Pharmaceuticals.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.